Bioscience, Biotechnology, and Biochemistry 1995-01-01

Synthesis of both the enantiomers of aseanostatin P5 (sarcinic acid), an inhibitor of myeloperoxidase release, and four diastereomers of aggreceride A, a platelet aggregation inhibitor.

T Kitahara, S Aono, K Mori

Index: Biosci. Biotechnol. Biochem. 59(1) , 78-82, (1995)

Full Text: HTML

Abstract

Both the enantiomers of aseanostatin P5 (sarcinic acid), an inhibitor of myeloperoxidase (MPO) release from human polymorphonuclear leukocytes (PMN), with high optical purity were synthesized by starting from (S)-2-methylbutanol and methyl (S)-3-hydroxy-2-methylpropanoate. They were converted to four diastereomers of aggreceride A, a platelet aggregation inhibitor.


Related Compounds

Related Articles:

Diglucosyl-glycerolipids from the marine sponge-associated Bacillus pumilus strain AAS3: their production, enzymatic modification and properties.

2004-05-01

[Appl. Microbiol. Biotechnol. 64(4) , 497-504, (2004)]

Antibacterial compounds from Siraitia grosvenorii leaves.

2011-05-01

[Nat. Prod. Res. 25 , 890-897, (2011)]

Purification and characterization of aseanostatins: actinomycete-derived fatty acid inhibitors to myeloperoxidase release from human polymorphonuclear leukocytes.

1991-05-01

[J. Antibiot. 44(5) , 524-32, (1991)]

Impact on lipid membrane organization by free branched-chain fatty acids.

2006-11-07

[Phys. Chem. Chem. Phys. 8(41) , 4792-7, (2006)]

Enantioselective determination of anteiso fatty acids in food samples.

2007-06-15

[Anal. Chem. 79(12) , 4696-701, (2007)]

More Articles...